Integra LifeSciences IART Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $235.05M-4.6% | $246.38M-10.9% | $276.4M-39.5% | $456.66M-11.1% | ||
| $28.69M+5.5% | $27.19M-16.8% | $32.69M— | $0— | ||
| $278.85M+2.4% | $272.37M+5.0% | $259.33M-1.6% | $263.47M+13.6% | ||
| $492.74M+14.8% | $429.09M+10.1% | $389.61M+20.0% | $324.58M+2.3% | ||
| $1.16B+7.2% | $1.08B+2.2% | $1.06B-8.9% | $1.16B+0.7% | ||
| $444.34M+9.5% | $405.72M+19.3% | $340.2M+9.3% | $311.3M-0.1% | ||
| $615.16M-43.9% | $1.1B+3.9% | $1.06B+1.6% | $1.04B+2.5% | ||
| $1.13B-6.0% | $1.21B+13.1% | $1.07B-5.2% | $1.13B-1.7% | ||
| $3.6B-10.8% | $4.04B+6.8% | $3.78B-2.8% | $3.89B+2.8% | ||
| $95.73M+16.0% | $82.5M-10.6% | $92.33M-9.6% | $102.1M+65.1% | ||
| $11.46M+9.3% | $10.48M+22.8% | $8.54M+17.7% | $7.25M+37.0% | ||
| —— | —— | —— | —— | ||
| $455.98M-50.6% | $922.13M+200% | $306.98M-4.3% | $320.91M-5.6% | ||
| $1.73B+59.0% | $1.09B+31.8% | $825.56M+12.6% | $733.15M-11.1% | ||
| $2.56B+2.7% | $2.49B+13.6% | $2.19B+5.2% | $2.09B-0.6% | ||
| 240M+26,101% | 916K+0.8% | 909K+0.4% | 905K+1.0% | ||
| $423.44M-54.9% | $939.92M-0.7% | $946.86M+7.7% | $879.12M+25.8% | ||
| $1.04B-32.5% | $1.55B-2.7% | $1.59B-12.0% | $1.8B+7.1% | ||
| $3.6B-10.8% | $4.04B+6.8% | $3.78B-2.8% | $3.89B+2.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Integra LifeSciences's total assets?
- Integra LifeSciences (IART) holds $3.6B in total assets, down 11.7% year over year.
- How much debt does Integra LifeSciences have?
- Integra LifeSciences carries $2.0B in total debt against $1.0B of shareholders' equity, a debt-to-equity ratio of 1.90.
- How much cash does Integra LifeSciences have?
- Integra LifeSciences holds $236.8M in cash and equivalents.
- Can Integra LifeSciences cover its short-term obligations?
- Its current ratio is 3.38 — current assets exceed current liabilities.
- Where does Integra LifeSciences's balance sheet data come from?
- Every line is extracted from Integra LifeSciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
